Jennifer Wu Speaks on Panel About BPCIA Litigation
December 6, 2023 — Founding Partner Jennifer Wu moderated an in-house counsel panel on current issues in Biologics Price Competition and Innovation (BPCIA) litigation on December 1, 2023 as part of the Practicing Law Institute’s Developments in Pharmaceutical and Biotech Patent Law 2023 program. The panelists Ryan Daniel (Fresenius), Petra Scamborova (Regeneron), Jill Schmidt (Genentech), …
Nick Groombridge and Steve Baughman Recognized as IAM Global Leaders
December 1, 2023—We are pleased to announce that founding partners Nick Groombridge and Steve Baughman were recognized in IAM’s 2024 Global Leaders Guide, which identifies leading practitioners in the patent field. Nick Groombridge is one of the nation’s leading trial lawyers, focusing exclusively on intellectual property litigation. Over the past 35 years, Nick has served …
NAPABA Honors Jennifer Wu’s “Distinguished” Pro Bono Work at 35th Anniversary Gala
Founding partner Jennifer Wu was honored by the National Asian Pacific American Bar Association (NAPABA) with the 2023 Pro Bono Award at its anniversary gala on November 11. The annual award recognizes an attorney or a team of attorneys for outstanding achievements in pro bono service that involved impact litigation to advance or protect civil rights …
Five Partners Recognized by Benchmark Litigation as “Litigation Stars” and “Future Stars
October 5, 2023 —We are pleased to announce that partners Nick Groombridge, Steven Baughman and Eric Stone have been recognized as “Litigation Stars” in the 2024 edition of Benchmark Litigation. Jennifer Wu and Megan F. Raymond have been recognized as “Future Stars” in the same edition. Nick Groombridge is one of the nation’s leading trial …
Firm Secures Significant PTAB Win for Novo Nordisk’s Blockbuster Diabetes and Obesity Treatment Drug
October 2, 2023 – Groombridge, Wu, Baughman & Stone successfully defended Novo Nordisk before the Patent Trial and Appeal Board against Mylan Pharmaceuticals in inter partes review (IPR) proceedings seeking to invalidate two Novo patents relating to its blockbuster semaglutide family of drugs, including Ozempic®, Wegovy®, and Rybelsus® (U.S. Patents Nos. 8,536,122 and 8,129,343). The …
Firm Wins a Major Victory on Behalf of Genentech
Groombridge, Wu, Baughman & Stone LLP won a major victory on behalf of Genentech in patent litigation brought by Baxalta, Inc. and Baxalta GmbH (now subsidiaries of Takeda Pharmaceuticals) concerning Genentech’s breakthrough Hemophilia A treatment, HEMLIBRA® (emicizumab-kxwh), which has transformed the lives of thousands of patients. The U.S. District Court for the District of Delaware …
Groombridge, Wu, Baughman & Stone LLP、東京丸の内に初の海外拠点をオープン
Groombridge, Wu, Baughman & Stone LLP (GWBS) はこの度東京に新オフィスを開設しました。米国における知的財産関連の案件 (ライセンス、訴訟、知財戦略に関するカウンセリング等) につき、東京在住の外国法事務弁護士マックスウェル (マック)・フォックスが日本のクライアントを全面的にサポートします。東京オフィスは9か月前に開設したGWBSのニューヨーク、ワシントンDCオフィスに次ぐ3番目の拠点となります。 Groombridge, Wu, Baughman & Stone LLPが東京オフィスを設立 – グローバル展開に向けた初の海外進出 | PR TIMES
Firm Opens First Overseas Office in Marunouchi, Tokyo
Groombridge, Wu, Baughman & Stone LLP proudly announces the opening of its newest office, in Tokyo. The office will represent Japan-based clients in intellectual property disputes in the United States, and is led by prominent Japan-based U.S. patent litigator Maxwell (“Mac”) Fox. This is the third office for our patent litigation firm, which launched a little more than nine …
Firm is Named “Firm to Watch” by LMG Life Sciences
We are pleased that our firm was chosen as the 2023 “Firm to Watch” by LMG Life Sciences Americas Awards.
Nick Groombridge Receives Recognition by Best Lawyers
We are pleased to announce that partner Nick Groombridge has been named in the Best Lawyers® 30th edition of “Best Lawyers in America” and has been recognized as the recipient of their 2024 “Lawyer of the Year” award for patent litigation work in New York City. The award is given to a single lawyer in each practice area and community, …